1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
  4. > Biopharmaceutical

Biopharmaceutical Sector: Get Market Research and Figures

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
30 votes

Global Biopharmaceutical Industry

The global biopharmaceutical industry (a part of the biotechnology market) is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

Key Biopharmaceutical Market Segments

The world biosimilar market is expected to record yearly growth in excess of 50% between 2010 and 2015, reports RNCOS. Market growth is being driven by factors such as costly drugs, high pharmaceutical expenditure and a global aging population. Market expansion will be further fuelled by expiring patents and the increasing cost of drugs. Sandoz is the leading company operating in the global biosimilars market, recording the highest sales. Teva and Hospira are developing a biosimilar product range.

The global enzyme market is expected to exceed $7.5 billion in 2015, reports Freedonia, and it should surpass yearly growth of 5%. The fastest rate of growth will be recorded in smaller markets such as the Africa/Middle East region, and Central and South America. Asia-Pacific is expected to record strong growth, while the EU and North America are forecast to record below-average growth.

The global protein therapeutics market is forecast to see yearly growth of 13% between 2012 and 2014, reports RNCOS. Increased investment and the introduction of new protein therapeutics will fuel market  expansion. Protein therapeutics have been recording a high rate of growth in recent years, vital to the treatment of many diseases. Protein therapeutics are particularly efficient due to their targeted approach, which allows the treatment of disease with little or no negative impact on healthy organs. Protein therapies are necessary in a healthcare landscape, witnessing rapidly rising rates of chronic illnesses like cardiovascular diseases, diabetes and cancer.

The cancer monoclonal antibodies market is expected to grow at a yearly rate in excess of 5% between 2012 and 2015, according to RNCOS. Cancer monoclonal antibodies are used to treat tumors with a high degree of specification. The market is driven by increasing prevalence of cancer and the need for more innovation research. The industry is witnessing rising consolidation.

Read more »

Customer Support

Talk to Sam

+33 4 37 65 17 06

330 Reports
Supply, Company, Demand
92 Statistics
Market Size, Finance, Company Financials
1600 Reports
Product Initiative, Supply, Company Financials
170 Statistics
Finance, Company Financials, Market Size
33 Reports
Demand, Company Financials, Company
21 Statistics
Demand, Market Size, Finance
160 Reports
Supply, Company Financials, Market Size
33 Statistics
Finance, Company Financials, Market Size
32 Reports
Supply, Company, Market Size
13 Statistics
Market Size, Supply, Company
51 Reports
Company Financials, Company, Market Size
2 Statistics
Finance, Company Financials, Market Size
32 Reports
Company Financials, Supply, Product Initiative
3 Statistics
Market Size, Company, Supply
20 Reports
Supply, Company, Company Financials
3 Statistics
Market Size, Demand, Finance
64 Reports
Supply, Market Description, Company Financials
6 Statistics
Finance, Company Financials, Market Size
26 Reports
Supply, Market Description, Market Size
1 Statistics
Market Size, Demand, Supply
Search in Biopharmaceutical Industry (About 2700 reports)
Parent industry: Medical Biotechnology

About 1900 reports

Purchase Reports From Reputable Market Research Publishers

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • € 9643
  • Industry report
  • October 2019

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028SummaryAxial spondyloarthritis (axSpA) is a disease group encompassing both ankylosing spondylitis (AS) and non-radiographic axial ...

Myasthenia Gravis: Opportunity Analysis and Forecasts t ... € 9643 October 2019

tislelizumab € 8770 September 2019

Gene Therapy in Neurology € 7012 September 2019

Frontier Pharma: Type 1 Diabetes Insulin Gene Therapy a ... € 6135 October 2019

Frontier Pharma - Small Cell Lung Cancer: Diverse First ... € 6135 September 2019

T-Cell Therapy Market Size, Share & Trends Analysis Rep ... € 5218 September 2019

Cell Analysis Market by Product, Process, End User - Gl ... € 4404 October 2019

3D Bioprinting Market by Component, Material, Applicati ... € 4404 October 2019

Global Gene Therapy Industry € 4911 October 2019


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on